HLK

Hulk

Dual-pathway growth-hormone protocol

Growth HormoneGH PulseRecovery

A dual-pathway growth-hormone protocol pairing CJC-1295 (no DAC) with Ipamorelin for pulsatile GH release that mimics natural physiology.

01About this protocol

Hulk is a growth-hormone protocol, built on the CJC-1295 (no DAC) and Ipamorelin combination. It pairs a GHRH-receptor analog with a selective GH secretagogue so the two act through complementary receptor mechanisms rather than a single pathway.

The no-DAC form of CJC-1295 — also known as Mod GRF 1-29 — is used specifically for its short half-life. That produces pulsatile GH release rather than a sustained elevation, keeping the signal closer to the body’s own rhythm.

02Why these together

03Components

In research the pair is handled either as a single blended vial (a 10 mg blend of 5 mg CJC-1295 + 5 mg Ipamorelin) or as two separate 5 mg vials, reconstituted with bacteriostatic water under sterile technique. Equal amounts of each are used for complementary effect — separate vials allow individual tolerance testing, while a blend trades that flexibility for convenience. Reputable sources supply a certificate of analysis (COA) with purity testing.

04Supporting foundation

Growth-hormone research is sensitive to timing around meals and insulin: food — especially carbohydrate and fat — blunts the GH response, so fasted timing is a common experimental variable. Protein and amino-acid availability provide the raw material for any adaptation.

See the foundation guide →

Research use only

All information on peptek is aggregated from public sources for research and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Peptide products referenced here are not for human consumption of any kind. Always consult a qualified healthcare professional before beginning any research protocol.